Soleno Therapeutics, Inc. (SLNO)
USD 68.29
(-5.36%)
USD 68.29
(-5.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -169.27 Million USD | -1071.72% |
| 2022 | -14.44 Million USD | 30.7% |
| 2021 | -20.84 Million USD | 57.53% |
| 2020 | -49.08 Million USD | -140.28% |
| 2019 | -20.42 Million USD | 11.56% |
| 2018 | -23.09 Million USD | -35.09% |
| 2017 | -17.09 Million USD | -527.28% |
| 2016 | -2.72 Million USD | 50.39% |
| 2015 | -5.49 Million USD | 30.05% |
| 2014 | -7.85 Million USD | -161.74% |
| 2013 | 12.72 Million USD | 41.74% |
| 2012 | 8.97 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -42.5 Million USD | 74.89% |
| 2024 Q2 | -56.72 Million USD | -33.48% |
| 2023 Q3 | -51.96 Million USD | -175.21% |
| 2023 Q4 | -169.27 Million USD | -225.74% |
| 2023 Q1 | -7.83 Million USD | 45.77% |
| 2023 Q2 | -18.88 Million USD | -141.01% |
| 2023 FY | -169.27 Million USD | -1071.72% |
| 2022 Q4 | -14.44 Million USD | 25.96% |
| 2022 Q1 | -28.55 Million USD | -36.95% |
| 2022 FY | -14.44 Million USD | 30.7% |
| 2022 Q2 | -23.72 Million USD | 16.89% |
| 2022 Q3 | -19.51 Million USD | 17.77% |
| 2021 Q1 | -41.55 Million USD | 15.35% |
| 2021 FY | -20.84 Million USD | 57.53% |
| 2021 Q4 | -20.84 Million USD | 24.52% |
| 2021 Q3 | -27.62 Million USD | 16.41% |
| 2021 Q2 | -33.04 Million USD | 20.47% |
| 2020 Q2 | -62.2 Million USD | -321.56% |
| 2020 Q1 | -14.75 Million USD | 27.77% |
| 2020 Q3 | -55.91 Million USD | 10.1% |
| 2020 Q4 | -49.08 Million USD | 12.22% |
| 2020 FY | -49.08 Million USD | -140.28% |
| 2019 Q1 | -19.4 Million USD | 16.01% |
| 2019 Q3 | -11.2 Million USD | 27.76% |
| 2019 FY | -20.42 Million USD | 11.56% |
| 2019 Q4 | -20.42 Million USD | -82.39% |
| 2019 Q2 | -15.5 Million USD | 20.1% |
| 2018 Q4 | -23.09 Million USD | -125.6% |
| 2018 Q2 | -12.59 Million USD | 15.29% |
| 2018 Q1 | -14.86 Million USD | 13.06% |
| 2018 FY | -23.09 Million USD | -35.09% |
| 2018 Q3 | -10.23 Million USD | 18.69% |
| 2017 Q3 | -5.64 Million USD | 25.18% |
| 2017 FY | -17.09 Million USD | -527.28% |
| 2017 Q4 | -17.09 Million USD | -202.81% |
| 2017 Q2 | -7.54 Million USD | 28.39% |
| 2017 Q1 | -10.53 Million USD | -286.61% |
| 2016 Q4 | -2.72 Million USD | 49.66% |
| 2016 FY | -2.72 Million USD | 50.39% |
| 2016 Q1 | -6.49 Million USD | -18.15% |
| 2016 Q2 | -2.5 Million USD | 61.46% |
| 2016 Q3 | -5.41 Million USD | -116.43% |
| 2015 Q1 | -9.52 Million USD | -21.31% |
| 2015 FY | -5.49 Million USD | 30.05% |
| 2015 Q2 | -7.53 Million USD | 20.98% |
| 2015 Q3 | -4.72 Million USD | 37.32% |
| 2015 Q4 | -5.49 Million USD | -16.41% |
| 2014 Q3 | 15.54 Million USD | 13.89% |
| 2014 Q2 | 13.64 Million USD | 0.21% |
| 2014 Q1 | 13.61 Million USD | 7.01% |
| 2014 Q4 | -7.85 Million USD | -150.55% |
| 2014 FY | -7.85 Million USD | -161.74% |
| 2013 FY | 12.72 Million USD | 41.74% |
| 2013 Q4 | 12.72 Million USD | 0.0% |
| 2013 Q1 | 2.15 Million USD | 0.0% |
| 2012 FY | 8.97 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -202.606% |
| Alkermes plc | -166.73 Million USD | -1.523% |
| Agenus Inc. | 274.13 Million USD | 161.75% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 109.053% |
| Aptorum Group Limited | 1.35 Million USD | 12574.006% |
| Ardelyx, Inc. | 34.51 Million USD | 590.49% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4055.093% |
| Bicycle Therapeutics plc | -481.46 Million USD | 64.841% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 568.097% |
| ChromaDex Corporation | -24.04 Million USD | -603.917% |
| Chimerix, Inc. | -25.51 Million USD | -563.393% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2529.336% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -614.947% |
| CRISPR Therapeutics AG | -150.84 Million USD | -12.22% |
| Precision BioSciences, Inc. | -85.41 Million USD | -98.195% |
| Dyadic International, Inc. | -6.37 Million USD | -2554.051% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -962.436% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2308.454% |
| Lantern Pharma Inc. | -21.7 Million USD | -679.965% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -53.141% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1881.441% |
| Incyte Corporation | -3.17 Billion USD | 94.669% |
| IO Biotech, Inc. | -140.69 Million USD | -20.312% |
| Jaguar Health, Inc. | 29.39 Million USD | 675.952% |
| Novavax, Inc. | -298.29 Million USD | 43.251% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3271.782% |
| Opthea Limited | 28.15 Million USD | 701.184% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -908.267% |
| ContextLogic Inc. | -232 Million USD | 27.035% |
| MiMedx Group, Inc. | -33.9 Million USD | -399.33% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1760.402% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7205.828% |
| NextCure, Inc. | -6.47 Million USD | -2513.525% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -235.197% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2553.676% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1491.715% |
| Vaxcyte, Inc. | -368.22 Million USD | 54.029% |
| PDS Biotechnology Corporation | -32.7 Million USD | -417.529% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1079.731% |
| Pharming Group N.V. | 109.8 Million USD | 254.164% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -873.086% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 3.397% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -814.035% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -814.035% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2284.197% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2788.703% |
| Acelyrin, Inc. | -216.9 Million USD | 21.957% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2917.29% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -9718.91% |
| Summit Therapeutics Inc. | 34.67 Million USD | 588.199% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2388.285% |
| Senti Biosciences, Inc. | 1.74 Million USD | 9828.621% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 8.304% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -118.561% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2692.445% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 169769.938% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 27055.096% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -44.625% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -0.621% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 252.682% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2128.515% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -31.107% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2555.227% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 30.155% |
| Immix Biopharma, Inc. | -17.5 Million USD | -866.762% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 46.55% |
| MEI Pharma, Inc. | -3.7 Million USD | -4468.907% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1453.033% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 204.659% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 709.067% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2308.454% |
| Precigen, Inc. | -481 Thousand USD | -35092.931% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1302.173% |
| AlloVir, Inc. | -62.69 Million USD | -170.015% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -204.38% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 374.508% |
| ImmuCell Corporation | 10.99 Million USD | 1640.212% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -9.817% |
| Onconetix, Inc. | 5.33 Million USD | 3275.091% |
| PureTech Health plc | -167.19 Million USD | -1.245% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -455.739% |
| Elevation Oncology, Inc. | -19.11 Million USD | -785.438% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3348.319% |
| Seer, Inc. | -4.24 Million USD | -3892.406% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -604.239% |
| Innoviva, Inc. | 255.56 Million USD | 166.237% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -203.018% |
| ESSA Pharma Inc. | -33.62 Million USD | -403.48% |
| GlycoMimetics, Inc. | -40.98 Million USD | -313.03% |
| GT Biopharma, Inc. | -1.02 Million USD | -16479.628% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -149.735% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 376.341% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -26.252% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1121.695% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -486.305% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -224603.321% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -448.5% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1965.661% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5309.94% |
| Soligenix, Inc. | -4.95 Million USD | -3318.655% |
| Century Therapeutics, Inc. | 847 Thousand USD | 20085.596% |
| Kura Oncology, Inc. | -20.11 Million USD | -741.426% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -313.62% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1915.694% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9392.335% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5194.901% |
| Autolus Therapeutics plc | -186.59 Million USD | 9.282% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -243.335% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 38.622% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 593.983% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 202.987% |
| GRI Bio, Inc. | -1.79 Million USD | -9335.786% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1784.416% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -409.0% |
| IGM Biosciences, Inc. | -72.6 Million USD | -133.146% |
| INmune Bio, Inc. | -25.41 Million USD | -566.16% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 212.141% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -234.152% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -941.751% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5767.672% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 545.293% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -311.019% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 630.902% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 144.788% |
| Verastem, Inc. | -37.27 Million USD | -354.096% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1765.733% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -226.401% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1018.454% |
| Histogen Inc. | -7.48 Million USD | -2160.959% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -683.447% |
| Surrozen, Inc. | -32.66 Million USD | -418.24% |
| Organovo Holdings, Inc. | -1.5 Million USD | -11132.78% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3927.084% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 992.807% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6570.872% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4173.099% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1919.747% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -289.664% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1061.279% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 46.564% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -23343.758% |
| Apollomics, Inc. | -27.39 Million USD | -517.916% |
| Amarin Corporation plc | -191.04 Million USD | 11.391% |
| Mesoblast Limited | 55.96 Million USD | 402.482% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1060.71% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -569.295% |
| Synaptogenix, Inc. | -28.66 Million USD | -490.611% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -17985.256% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 447.365% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19535.792% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2229.702% |
| Exelixis, Inc. | -73.05 Million USD | -131.729% |
| Better Therapeutics, Inc. | -860 Thousand USD | -19583.488% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -604.943% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 29.868% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23097.666% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2175.812% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 13599.043% |
| Gritstone bio, Inc. | 39.49 Million USD | 528.66% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -101.279% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6331.193% |
| Avid Bioservices, Inc. | 169.72 Million USD | 199.735% |
| Insmed Incorporated | 721.62 Million USD | 123.458% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1751.751% |
| MediWound Ltd. | -5.32 Million USD | -3080.722% |
| OmniAb, Inc. | 9.2 Million USD | 1939.378% |
| Alector, Inc. | -35.63 Million USD | -375.006% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 296.901% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3335.024% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1378.631% |
| Zai Lab Limited | -775 Million USD | 78.158% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 149.707% |
| Aura Biosciences, Inc. | -21.52 Million USD | -686.425% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -105.235% |
| Immunic, Inc. | -45.34 Million USD | -273.352% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 12.389% |
| Veracyte, Inc. | -203.82 Million USD | 16.949% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 126.52% |
| FibroGen, Inc. | 56.76 Million USD | 398.198% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2000.932% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -5887.729% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8076.307% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.688% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4966.687% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -1.997% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1047.699% |
| Galecto, Inc. | -21.21 Million USD | -697.879% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -611.701% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 110.786% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -591.721% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1371.087% |
| XBiotech Inc. | -200.02 Million USD | 15.371% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -101.279% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3838.472% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -380.044% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -119.221% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3074.486% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 0.667% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -83.253% |
| Vaxxinity, Inc. | 10.13 Million USD | 1770.726% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 122.991% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1472.112% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -156.653% |
| NexImmune, Inc. | -3.13 Million USD | -5301.955% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4802.81% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1020.197% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -524.642% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1785.885% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -135784.407% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -317.229% |
| Ainos, Inc. | 4.07 Million USD | 4251.079% |
| Pluri Inc. | 22.82 Million USD | 841.504% |
| Prothena Corporation plc | -608.34 Million USD | 72.174% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -42.543% |
| Celularity Inc. | 65.19 Million USD | 359.669% |
| Rallybio Corporation | -24.1 Million USD | -602.34% |
| Cue Biopharma, Inc. | -33.81 Million USD | -400.541% |
| MeiraGTx Holdings plc | -40.3 Million USD | -320.024% |
| Omeros Corporation | 331.17 Million USD | 151.114% |
| Humacyte, Inc. | -22.48 Million USD | -652.815% |
| Immunocore Holdings plc | -358.59 Million USD | 52.794% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -588.822% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -447.808% |
| Blueprint Medicines Corporation | 702.83 Million USD | 124.085% |
| CalciMedica, Inc. | -5.53 Million USD | -2961.085% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 10.064% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1557.313% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -322.804% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -409.061% |
| Pulmatrix, Inc. | -10.41 Million USD | -1525.017% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2732.157% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -343.81% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -51.952% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -182.394% |
| Cytokinetics, Incorporated | 642.37 Million USD | 126.352% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2807.058% |
| Nutriband Inc. | -251.65 Thousand USD | -67165.365% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -396.14% |
| Vor Biopharma Inc. | 4.3 Million USD | 4036.698% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.196% |
| Evogene Ltd. | -19.63 Million USD | -762.168% |
| ProKidney Corp. | -56.23 Million USD | -201.014% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -247.793% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1732.571% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 112.411% |
| CorMedix Inc. | -43.05 Million USD | -293.19% |
| BioLineRx Ltd. | 7.33 Million USD | 2407.497% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -516.341% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 466.823% |
| Atai Life Sciences N.V. | -28.55 Million USD | -492.752% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 7689.141% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -641.927% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1054.485% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -125.482% |
| MediciNova, Inc. | -50.78 Million USD | -233.333% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -114.806% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -752413.892% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2523.412% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 15.285% |
| Biomea Fusion, Inc. | -166.57 Million USD | -1.626% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 5.418% |
| Mereo BioPharma Group plc | -51.46 Million USD | -228.893% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -78.48% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 42.375% |
| Absci Corporation | -72.59 Million USD | -133.172% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3807.359% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 27.794% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -79.68% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -76.891% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -333.235% |
| Allakos Inc. | -24.97 Million USD | -577.79% |
| Imunon, Inc. | -4.21 Million USD | -3917.18% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1048.27% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -25.021% |
| BioAtla, Inc. | -109.01 Million USD | -55.285% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23097.666% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -17927.476% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1514.658% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -698.368% |
| XOMA Corporation | -29 Million USD | -483.717% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -922.21% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1777.529% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2172.493% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -35.818% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 18.68% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -106.994% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -82.484% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -19602.183% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4302.549% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10530.651% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.259% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14147.371% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3955.113% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 249.169% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 235332.484% |
| Orgenesis Inc. | 21.78 Million USD | 877.075% |
| Entera Bio Ltd. | -10.62 Million USD | -1492.605% |
| GH Research PLC | -78.07 Million USD | -116.809% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -659.503% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -534.975% |
| Xencor, Inc. | 29.64 Million USD | 671.036% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8493.612% |
| Replimune Group, Inc. | 1.41 Million USD | 12088.527% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -69019.016% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -33.904% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14147.371% |
| Portage Biotech Inc. | -4.98 Million USD | -3298.474% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -752413.892% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -156.009% |
| OncoCyte Corporation | -6.56 Million USD | -2479.278% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 18962.887% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3615.787% |
| Purple Biotech Ltd. | -14.13 Million USD | -1097.326% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -612.569% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2486.371% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -914.117% |
| HilleVax, Inc. | -165.48 Million USD | -2.292% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6569.74% |
| Tharimmune, Inc. | -10.93 Million USD | -1447.989% |
| Genprex, Inc. | -6.73 Million USD | -2412.427% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 54.101% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -91.361% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -11982.655% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5003.429% |
| OKYO Pharma Limited | -826.84 Thousand USD | -20372.687% |
| Savara Inc. | 153 Thousand USD | 110739.216% |
| Curis, Inc. | -23.88 Million USD | -608.662% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3181.91% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -21713.838% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2626.772% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 14385.063% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.487% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1471.95% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 72.168% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 8.787% |
| Erasca, Inc. | -37.21 Million USD | -354.853% |
| bluebird bio, Inc. | 108.57 Million USD | 255.915% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13043.794% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 144.694% |
| DBV Technologies S.A. | -126.98 Million USD | -33.304% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13043.794% |
| Moderna, Inc. | -2.9 Billion USD | 94.177% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1535.22% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1457.582% |
| Molecular Templates, Inc. | 707 Thousand USD | 24043.14% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -439.6% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 148.838% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -106.281% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -84.539% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -424.535% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -392.431% |
| MacroGenics, Inc. | -66.98 Million USD | -152.71% |
| RenovoRx, Inc. | -1.17 Million USD | -14331.202% |
| Adicet Bio, Inc. | -138.78 Million USD | -21.97% |
| Prime Medicine, Inc. | -27.94 Million USD | -505.841% |
| Aditxt, Inc. | 18.12 Million USD | 1034.16% |
| Adagene Inc. | -87.62 Million USD | -93.179% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3963.88% |
| Quantum-Si incorporated | -118.55 Million USD | -42.782% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 570.151% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2164.835% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -248.962% |
| SciSparc Ltd. | -2.06 Million USD | -8097.482% |
| Vericel Corporation | 1.27 Million USD | 13355.912% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1311.626% |
| Minerva Neurosciences, Inc. | 41 Million USD | 512.83% |
| Generation Bio Co. | 31.44 Million USD | 638.279% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 3.47% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -447.418% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 245.187% |
| Invivyd, Inc. | -198.47 Million USD | 14.711% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -87.524% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -6960.05% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -139.127% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2380.264% |
| 2seventy bio, Inc. | 181.71 Million USD | 193.156% |
| ADMA Biologics, Inc. | 90.06 Million USD | 287.949% |
| Clene Inc. | 3.34 Million USD | 5168.204% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1763.74% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -686.937% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2523.412% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 50.809% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -551.077% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 195.279% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4037.241% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3484.206% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3149.722% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -29.91% |
| Evaxion Biotech A/S | 5.28 Million USD | 3301.872% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -50.378% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -28.951% |
| Trevena, Inc. | 2.25 Million USD | 7596.811% |
| Surrozen, Inc. | -32.66 Million USD | -418.24% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -228.631% |
| Cingulate Inc. | 3.08 Million USD | 5591.256% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5663.636% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2455.336% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1721.912% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -113.403% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -28.776% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -60.389% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4193.522% |
| Kronos Bio, Inc. | -36.05 Million USD | -369.512% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1899.107% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11709.277% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -211.999% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1274.204% |
| ImmunityBio, Inc. | 618.22 Million USD | 127.381% |
| Korro Bio, Inc. | -132.94 Million USD | -27.331% |
| Kineta, Inc. | -4.54 Million USD | -3627.769% |
| BioVie Inc. | -17.73 Million USD | -854.628% |
| Codexis, Inc. | -43.27 Million USD | -291.204% |
| Celularity Inc. | 65.19 Million USD | 359.669% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5241.685% |
| Celcuity Inc. | 6.78 Million USD | 2595.434% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4930.633% |
| Cibus, Inc. | -8.07 Million USD | -1995.543% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3902.79% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3804.114% |
| IN8bio, Inc. | -16.38 Million USD | -932.876% |
| Kodiak Sciences Inc. | -103.87 Million USD | -62.963% |
| Annexon, Inc. | -193.75 Million USD | 12.633% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 470316.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -867.358% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4718.617% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 116.056% |
| Eyenovia, Inc. | 1.25 Million USD | 13548.616% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 729.169% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5119.796% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -409.153% |
| Arcellx, Inc. | -296.95 Million USD | 42.996% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -767.825% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -187.521% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -716.703% |
| Moolec Science SA | 117.61 Thousand USD | 144024.296% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -340.84% |
| Geron Corporation | 14.76 Million USD | 1246.792% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -346.432% |
| Royalty Pharma plc | 5.65 Billion USD | 102.992% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -19.698% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2321.916% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3056.488% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -20.285% |
| Humacyte, Inc. | -22.48 Million USD | -652.815% |
| Structure Therapeutics Inc. | -124.33 Million USD | -36.142% |
| 89bio, Inc. | -289.05 Million USD | 41.437% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -570.62% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9393.999% |
| Genelux Corporation | -6.89 Million USD | -2353.66% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -445.021% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 302.488% |
| Notable Labs, Ltd. | -9.77 Million USD | -1631.567% |
| Liquidia Corporation | -80.17 Million USD | -111.133% |
| Mustang Bio, Inc. | -3.73 Million USD | -4430.996% |
| Immunovant, Inc. | -635.22 Million USD | 73.352% |
| Quantum-Si incorporated | -118.55 Million USD | -42.782% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -863.778% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3985.88% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2208.858% |
| Acasti Pharma Inc. | -23 Million USD | -635.831% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4927.22% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -941.751% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -22.897% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5331.911% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -661.416% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -811.616% |
| PepGen Inc. | -60.67 Million USD | -179.014% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -636.76% |
| United Therapeutics Corporation | -507.7 Million USD | 66.658% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -785.067% |
| Solid Biosciences Inc. | -47.75 Million USD | -254.509% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19535.792% |
| Immuneering Corporation | -54.94 Million USD | -208.098% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3927.084% |
| Silo Pharma, Inc. | -3.52 Million USD | -4703.156% |
| Belite Bio, Inc | -87.27 Million USD | -93.968% |
| XOMA Corporation | -29 Million USD | -483.717% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -139.442% |
| Bionomics Limited | 227 Million USD | 174.569% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -45.575% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6582.906% |
| uniQure N.V. | -102.95 Million USD | -64.426% |
| Cassava Sciences, Inc. | -121.13 Million USD | -39.742% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3963.88% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 513.367% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1315.25% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5370.816% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 159796.226% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5119.796% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2000.932% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2182.605% |
| Altimmune, Inc. | -134.48 Million USD | -25.869% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 185.466% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6582.906% |
| Compugen Ltd. | -12.9 Million USD | -1211.826% |
| Peak Bio, Inc. | 10.34 Million USD | 1737.093% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -59715.548% |
| Benitec Biopharma Inc. | -50.58 Million USD | -234.661% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -62.24% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 961.685% |
| Zura Bio Limited | -99.8 Million USD | -69.607% |
| PolyPid Ltd. | 6.17 Million USD | 2843.566% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 328.384% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 961.685% |
| Instil Bio, Inc. | 75.35 Million USD | 324.632% |
| argenx SE | -2.02 Billion USD | 91.656% |
| Immunome, Inc. | -97.02 Million USD | -74.461% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -652.514% |
| Verona Pharma plc | -220.44 Million USD | 23.21% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -135.951% |
| Shattuck Labs, Inc. | -121.42 Million USD | -39.411% |
| CervoMed Inc. | -7.79 Million USD | -2072.223% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 8.745% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3770.981% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -28.494% |
| Moolec Science SA | 117.61 Thousand USD | 144024.296% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7298.588% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1164.75% |
| AnaptysBio, Inc. | -18.15 Million USD | -832.61% |
| Design Therapeutics, Inc. | -18.15 Million USD | -832.661% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -140.517% |
| NeurAxis, Inc. | 145.7 Thousand USD | 116282.567% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1607.105% |
| Lumos Pharma, Inc. | -28.49 Million USD | -494.104% |
| Achilles Therapeutics plc | -126.92 Million USD | -33.37% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -135.951% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -25715.198% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -714.862% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11709.277% |
| Nutriband Inc. | -251.65 Thousand USD | -67165.365% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1185.233% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2175.242% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 149.759% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 813.2% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 62.17% |
| Palisade Bio, Inc. | -12.06 Million USD | -1303.283% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -20.645% |
| Beam Therapeutics Inc. | -262.72 Million USD | 35.568% |
| Neurogene Inc. | -131.95 Million USD | -28.285% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 875.935% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3368.811% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 55.121% |
| Sesen Bio, Inc. | -112.55 Million USD | -50.398% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -69.515% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7110.09% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -333.757% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -103.259% |
| Athira Pharma, Inc. | -88.99 Million USD | -90.202% |
| Vaccinex, Inc. | -1.28 Million USD | -13042.702% |
| HCW Biologics Inc. | 2.85 Million USD | 6025.698% |
| XOMA Corporation | -29 Million USD | -483.717% |
| Nektar Therapeutics | 210.24 Million USD | 180.517% |
| Arvinas, Inc. | -313.8 Million USD | 46.055% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10530.651% |
| Merus N.V. | -192.88 Million USD | 12.238% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 382.201% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2339.867% |
| Rezolute, Inc. | -68.16 Million USD | -148.325% |
| Clene Inc. | 3.34 Million USD | 5168.204% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1183.673% |
| BeyondSpring Inc. | -13.75 Million USD | -1130.665% |
| Synlogic, Inc. | -6.68 Million USD | -2432.206% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 15027.513% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1902.105% |
| Peak Bio, Inc. | 10.34 Million USD | 1737.093% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -105.385% |
| Krystal Biotech, Inc. | -350.23 Million USD | 51.667% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 236.377% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -0.167% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5261.745% |
| MannKind Corporation | 143.89 Million USD | 217.637% |
| Ikena Oncology, Inc. | -109.15 Million USD | -55.079% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2135.874% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -411.414% |
| Gossamer Bio, Inc. | 180.35 Million USD | 193.858% |
| CohBar, Inc. | -5.93 Million USD | -2754.252% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -469.04% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3807.359% |
| Legend Biotech Corporation | -949.39 Million USD | 82.17% |
| Mural Oncology plc | -255.84 Million USD | 33.835% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 625.463% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3493.523% |
| Disc Medicine, Inc. | -358.28 Million USD | 52.753% |
| Champions Oncology, Inc. | 4.81 Million USD | 3617.83% |
| REGENXBIO Inc. | 54.76 Million USD | 409.082% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -62850.388% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -12.087% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1778.361% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -109.806% |
| Vaxart, Inc. | -8.24 Million USD | -1954.095% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -237.342% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -33.116% |
| Cellectis S.A. | -43.85 Million USD | -285.995% |
| Longeveron Inc. | -2.9 Million USD | -5721.114% |
| Repare Therapeutics Inc. | -107.85 Million USD | -56.945% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 117.481% |
| Inozyme Pharma, Inc. | 12 Million USD | 1510.18% |
| Revolution Medicines, Inc. | -608.2 Million USD | 72.168% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -13662.439% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 36.15% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -12.798% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -981.856% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -22775.405% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.23% |
| Denali Therapeutics Inc. | -74.86 Million USD | -126.111% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1311.626% |
| Veru Inc. | 4.77 Million USD | 3641.404% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1405.229% |
| Cingulate Inc. | 3.08 Million USD | 5591.256% |
| Passage Bio, Inc. | 4.58 Million USD | 3791.996% |
| Context Therapeutics Inc. | -14.44 Million USD | -1071.488% |
| Exicure, Inc. | 5.84 Million USD | 2994.136% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 26.521% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -327.794% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1178.822% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -187.785% |
| Nuvalent, Inc. | -335.38 Million USD | 49.528% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 9860.364% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -127.274% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1804.139% |
| OmniAb, Inc. | 9.2 Million USD | 1939.378% |
| Anew Medical, Inc. | 1.43 Million USD | 11917.252% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1133.333% |
| Lipocine Inc. | -4.75 Million USD | -3460.305% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -54.13% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1211.404% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -234.152% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 780.05% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2418.643% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -157.156% |
| Ocugen, Inc. | -32.52 Million USD | -420.519% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -97.812% |
| Q32 Bio Inc. | -37.94 Million USD | -346.079% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -26855.096% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1151.223% |
| Equillium, Inc. | -22.39 Million USD | -655.975% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -562.07% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -418.832% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -68180.661% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 226.287% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5393.246% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 51639.85% |
| Dominari Holdings Inc. | 195 Thousand USD | 86909.231% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3113.991% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1798.374% |
| Bio-Techne Corporation | 267.74 Million USD | 163.223% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -944.346% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -43.342% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1914.495% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1238.06% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 30.94% |
| Nkarta, Inc. | 57.29 Million USD | 395.429% |
| BioCardia, Inc. | 212 Thousand USD | 79948.113% |
| Iterum Therapeutics plc | 13.43 Million USD | 1359.696% |